Abstract
Recently, a drug-eluting balloon (DEB) has emerged as a potential therapeutic option and has been widely adopted for treating in-stent restenosis. However, the benefits of DEB are still uncertain for de novo coronary lesions. From January 2010 through April 2016, 171 consecutive patients with de
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.